Early rhythm-control therapy in patients with atrial fibrillation P Kirchhof, AJ Camm, A Goette, A Brandes, L Eckardt, A Elvan, T Fetsch, ... New England Journal of Medicine 383 (14), 1305-1316, 2020 | 1497 | 2020 |
Cardiac-resynchronization therapy in heart failure with a narrow QRS complex F Ruschitzka, WT Abraham, JP Singh, JJ Bax, JS Borer, J Brugada, ... New England Journal of Medicine 369 (15), 1395-1405, 2013 | 959 | 2013 |
Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial MR Gold, DJ Van Veldhuisen, PJ Hauptman, M Borggrefe, SH Kubo, ... Journal of the American College of Cardiology 68 (2), 149-158, 2016 | 364 | 2016 |
The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias MJ Curtis, JC Hancox, A Farkas, CL Wainwright, CL Stables, DA Saint, ... Pharmacology & therapeutics 139 (2), 213-248, 2013 | 311 | 2013 |
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial A Goette, JL Merino, MD Ezekowitz, D Zamoryakhin, M Melino, J Jin, ... The Lancet 388 (10055), 1995-2003, 2016 | 278 | 2016 |
Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis H Jilaihawi, D Chin, M Vasa-Nicotera, M Jeilan, T Spyt, GA Ng, J Bence, ... American heart journal 157 (5), 860-866, 2009 | 266 | 2009 |
Remote management of heart failure using implantable electronic devices JM Morgan, S Kitt, J Gill, JM McComb, GA Ng, J Raftery, P Roderick, ... European heart journal 38 (30), 2352-2360, 2017 | 254 | 2017 |
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation P Kirchhof, KG Haeusler, B Blank, J De Bono, D Callans, A Elvan, ... European heart journal 39 (32), 2942-2955, 2018 | 238 | 2018 |
Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart GA Ng, KE Brack, VH Patel, JH Coote Cardiovascular research 73 (4), 750-760, 2007 | 238 | 2007 |
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint … CS Anderson, Y Huang, RI Lindley, X Chen, H Arima, G Chen, Q Li, ... The Lancet 393 (10174), 877-888, 2019 | 234 | 2019 |
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial MD Lobo, PA Sobotka, A Stanton, JR Cockcroft, N Sulke, E Dolan, ... The Lancet 385 (9978), 1634-1641, 2015 | 227 | 2015 |
Treating patients with ventricular ectopic beats GA Ng Heart 92 (11), 1707-1712, 2006 | 217 | 2006 |
Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial MR Gold, PD Lambiase, MF El-Chami, RE Knops, JD Aasbo, ... Circulation 143 (1), 7-17, 2021 | 176 | 2021 |
Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart–a novel model of isolated Langendorff perfused rabbit heart with intact dual … GA Ng, KE Brack, JH Coote Experimental physiology 86 (3), 319-329, 2001 | 171 | 2001 |
First experience with a novel robotic remote catheter system: Amigo™ mapping trial EM Khan, W Frumkin, GA Ng, S Neelagaru, FM Abi-Samra, J Lee, ... Journal of Interventional Cardiac Electrophysiology 37, 121-129, 2013 | 161 | 2013 |
Early rhythm control therapy in patients with atrial fibrillation and heart failure A Rillig, C Magnussen, AK Ozga, A Suling, A Brandes, G Breithardt, ... Circulation 144 (11), 845-858, 2021 | 156 | 2021 |
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial S Willems, K Borof, A Brandes, G Breithardt, AJ Camm, HJGM Crijns, ... European heart journal 43 (12), 1219-1230, 2022 | 134 | 2022 |
Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy? MF Yuyun, LL Ng, GA Ng Microvascular research 119, 7-12, 2018 | 133 | 2018 |
Anticoagulation with edoxaban in patients with atrial high-rate episodes P Kirchhof, T Toennis, A Goette, AJ Camm, HC Diener, N Becher, ... New England Journal of Medicine 389 (13), 1167-1179, 2023 | 129 | 2023 |
Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial J Brugada, PP Delnoy, J Brachmann, D Reynolds, L Padeletti, G Noelker, ... European Heart Journal 38 (10), 730-738, 2017 | 129 | 2017 |